Status
Conditions
Treatments
About
. Treatment with dequalinium chloride vaginal tablets for 6 days had a cure rate lower than expected; only 37% of patients were considered cured one month after treatment.
Full description
This is the first study to utilize a molecular diagnostic test as a test of cure for bacterial vaginosis. The Nugent score is a reliable method for diagnosing bacterial vaginosis, but similar to traditional clinical diagnostic methods, it is not equally reliable when utilized as a test of cure. This study demonstrated that molecular diagnostic testing can be used as a test of cure and this is the first molecular test that can do that. Treatment with dequalinium chloride vaginal tablets for 6 days had a cure rate lower than expected; only 37% of patients were considered cured one month after treatment.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
BV
Exclusion criteria
No other infection (Gc, clhlamydia, trihomonas)
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal